Shanxi Qianyecao Biotech QYC Safety Rating & Test Results

As of 9 Aug 2026, Finnrick has published 122 independent lab tests of 9 peptides from Shanxi Qianyecao Biotech QYC: 82 passed and 40 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 5 Aug 2026.

Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.

Purchased from Shanxi Qianyecao Biotech QYC? Submit a sample to Finnrick for free independent lab testing — results are published publicly.

Are you Shanxi Qianyecao Biotech QYC? Finnrick offers professional testing services and a public launch program for peptide vendors.

Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.

Shanxi Qianyecao Biotech QYC peptides tested by Finnrick, rated under the default public methodology.
PeptideFinnrick ratingLab testsLatest test
BPC-15744%823 Jul 2026
Cagrilintide41%517 Jul 2026
GHK-Cu91%1228 Apr 2026
Ipamorelin59%55 Aug 2026
NAD+18%38 Jun 2026
Retatrutide74%515 Aug 2026
TB-50039%417 Jul 2026
Tesamorelin57%1221 Jul 2026
Tirzepatide81%2221 Jul 2026